Atlas Trials

The Use of Tranexamic Acid in the Treatment of Symptomatic Subdural Hematoma

Clinical trial NCT05713630 · RECRUITING

Trial details

NCT number
NCT05713630
Sponsor
Unity Health Toronto
Status
RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Subdural Hematoma
Start date
2026-05-20
Primary completion
2027-03-30
Enrollment
130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.